Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction
- 28 August 2006
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 349 (2), 683-693
- https://doi.org/10.1016/j.bbrc.2006.08.115
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Role of Endothelial Dysfunction in AtherosclerosisCirculation, 2004
- Down-regulating effect of nicotine on connexin43 gap junctions in human umbilical vein endothelial cells is attenuated by statinsEuropean Journal of Cell Biology, 2004
- The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factorCardiovascular Research, 2003
- Epidemiology of smoking-induced cardiovascular diseaseProgress in Cardiovascular Diseases, 2003
- Smoking and endothelial functionProgress in Cardiovascular Diseases, 2003
- Impairment of nitric oxide synthase-dependent dilatation of cerebral arterioles during infusion of nicotineAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- Association of Asymmetric Dimethylarginine and Endothelial Dysfunctioncclm, 2003
- Nicotine impairs endothelium-dependent dilatation in human veins in vivoClinical Pharmacology & Therapeutics, 2000
- Superoxide dismutase restores endothelium-dependent arteriolar dilatation during acute infusion of nicotineJournal of Applied Physiology, 1998
- Central and Peripheral Effects of Asymmetric Dimethylarginine, an Endogenous Nitric Oxide Synthetase InhibitorJournal of Cardiovascular Pharmacology, 1996